Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer

NCT01283204 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Recurrent or Metastatic Gastric Cancer

Interventions

DRUG: SP
DRUG: FL/Tax
DRUG: FL/Doc
DRUG: FOLFOX

Sponsor

Yonsei University